The population dynamics of antimicrobial chemotherapy

被引:186
作者
Lipsitch, M
Levin, BR
机构
关键词
D O I
10.1128/AAC.41.2.363
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We present and analyze a series of mathematical models for the emergence of resistance during antibiotic treatment of an infected host. The models consider the population dynamics of antibiotic-sensitive and -resistant bacteria during the course of treatment and addresses the following problems: (i) the probability of obtaining a resistant mutant during the course of treatment as a function of antibiotic exposure; (ii) the conditions under which high, infrequent doses of an antibiotic are predicted to succeed in preventing the emergence of resistance; (iii) the conditions for the success of multiple drug treatment in suppressing the emergence of resistance and the relationship between antibiotic synergism and suppression of resistance; and (iv) the conditions under which nonadherence to the prescribed treatment regimen is predicted to result in treatment failure due to resistance. We analyze the predictions of the model for interpreting and extrapolating existing experimental studies of treatment efficacy and for optimizing treatment protocols to prevent the emergence of resistance.
引用
收藏
页码:363 / 373
页数:11
相关论文
共 55 条
  • [1] ALTARAC D, 1994, IMPROVING TUBERCULOS, P53
  • [2] [Anonymous], MMWR RECOMM REP
  • [3] AUSTIN DJ, IN PRESS J THEOR BIO
  • [4] COMPARATIVE-STUDY WITH ENOXACIN AND NETILMICIN IN A PHARMACODYNAMIC MODEL TO DETERMINE IMPORTANCE OF RATIO OF ANTIBIOTIC PEAK CONCENTRATION TO MIC FOR BACTERICIDAL ACTIVITY AND EMERGENCE OF RESISTANCE
    BLASER, J
    STONE, BB
    GRONER, MC
    ZINNER, SH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) : 1054 - 1060
  • [5] The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA
    Bradford, WZ
    Martin, JN
    Reingold, AL
    Schecter, GF
    Hopewell, PC
    Small, PM
    [J]. LANCET, 1996, 348 (9032) : 928 - 931
  • [6] BRADY MS, 1988, J ASSOC OFF ANA CHEM, V71, P295
  • [7] POSSIBLE PREVENTION OF IN-VITRO SELECTION OF RESISTANT STREPTOCOCCUS-PNEUMONIAE BY BETA-LACTAMASE INHIBITORS
    CARSENTIETESSE, H
    DURANT, J
    DESALVADOR, F
    BENSOUSSAN, M
    BENSOUSSAN, F
    PRADIER, C
    BERNARD, E
    MONDAIN, V
    THABAUT, A
    DELLAMONICA, P
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (12) : 1058 - 1062
  • [8] THE COMPARATIVE PHARMACOKINETICS AND TISSUE PENETRATION OF SINGLE-DOSE CIPROFLOXACIN 400 MG IV AND 750 MG PO
    CATCHPOLE, C
    ANDREWS, JM
    WOODCOCK, J
    WISE, R
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (01) : 103 - 110
  • [9] THE POSTANTIBIOTIC EFFECT
    CRAIG, WA
    VOGELMAN, B
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) : 900 - 902
  • [10] CRAIG WA, 1988, INFECT CONT HOSP EP, V9, P417